C Terminal Variants of FSH Receptor
Launched by UNIVERSITY HOSPITAL, TOURS · Jan 30, 2012
Trial Information
Current as of June 04, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • patients above 18 years,
- • entering an IVF cycle
- • informed consent
- • NHS operative
- Exclusion Criteria:
- • No
About University Hospital, Tours
The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
Patients applied
Trial Officials
Dominique ROYERE
Principal Investigator
Tours Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials